MarketLens
Sign Up

What's Fueling Olema Pharmaceuticals' Explosive 242% Stock Surge

8 months ago
SHARE THIS ON:

What's Fueling Olema Pharmaceuticals' Explosive 242% Stock Surge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 months ago

Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027

Olema Pharmaceuticals (OLMA) shares fell Tuesday after the company completed enrollment in its pivotal Phase 3 OPERA-01 trial, with top-line data now expected in Q1 2027.
Stock News•3 months ago

Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher?

Iovance Biotherapeutics' Q2 revenue rose 66% on strong Amtagvi demand, while losses narrowed nearly 60%. The results could support further upside if sales momentum continues.
Stock News•4 months ago

This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks

Psychedelic pharma stock soared ~50% after a report that Eli Lilly is in takeover talks at a premium, per the report.

Breaking News

View All →

Top Headlines

View More →
Stock News•18 minutes ago

California AG Rob Bonta serves Nvidia with subpoena in wake of ex-CEO Jensen Huang's Chinese spy, affairs scandals

Stock News•48 minutes ago

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages NVIDIA Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NVDA

Stock News•50 minutes ago

Alibaba defrauded shareholders by concealing ties to suspected spy in Nvidia scandal, lawsuit says

Stock News•1 hour ago

GOOGL; GOOG DEADLINE FOR INVESTORS: Alphabet Inc. Shareholders Encouraged to Contact Kirby McInerney LLP By December 1, 2026

Stock News•1 hour ago

California AG issues subpoena to Nvidia in probe of China chips